{"summary": "the woman, 32 weeks pregnant, sought medical care for fever and back pain. she reported 3 earlier pregnancies (2 live births) and no concurrent conditions. the patient declined admission but returned to the ED on November 22 with worsening fever, cough, and shortness of breath. the assay contains reagents and enzyme for specific amplification of the region upstream of the envelope gene in the CoV genome. the detection limit of the assay is 3.4 copies per reaction. on November 26, oral ribavirin was increased to 1,200 mg every 8 hours. on November 27, ribavirin was increased to 1,200 mg every 8 hours. despite intensive support, the patient\u2019s condition continued to deteriorate. patients infected with MERS-CoV typically show signs of respiratory illness (2) and sometimes diarrhea. complications include acute renal failure and acute respiratory distress syndrome with shock. pregnant patients may have atypical signs and symptoms. ERS-CoV infection and pregnancy were a fatal combination for the patient in our study. virus shedding ceased in the patient during therapy with ribavirin and peginterferon-. knowledge about the use of these drugs is limited; therefore, further studies are needed. CoV infection."}